Researchers and clinicians have developed major new guidelines for the monitoring of patients with inflammatory bowel disease ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

Despite improved treatments and regular check-ups, people with inflammatory bowel disease - which includes Crohn’s disease and ulcerative colitis ... years after their symptoms start, and any patients ...

In this Healio video, Edward L. Barnes, MD, MPH, associate professor of medicine, co-director of the Multidisciplinary IBD Center and associate fellowship program director at the University of North ...

CHARLOTTE, N.C. -- Wide receiver Hunter Renfrow dropped from 185 pounds to 150 pounds last year while being treated for ulcerative colitis, which played a big role in his decision to step away ...

study in adults with moderately-to-severely active ulcerative colitis (UC). These data are among 24 abstracts highlighting the Company's research being presented at Digestive Disease Week (DDW ...

Ulcerative colitis (UC) is “a type of inflammatory bowel disease (IBD) that causes inflammation and sores, called ulcers, in part of the digestive tract.” Symptoms can develop over time ...

Johnson & Johnson’s inflammatory disease drug Stelara has been approved in Europe for ulcerative colitis (UC), a new use for the multibillion dollar blockbuster. The European Commission cleared ...

Up to 25,000 people with ulcerative colitis (UC) in England could be in ... but some of the most common symptoms include diarrhoea, fatigue, cramping pains, loss of appetite, and weight loss ...

The interleukin-23p19 inhibitor guselkumab has demonstrated significant benefits as both induction and maintenance therapy in patients with moderately to severely active ulcerative colitis (UC), ...